ArticlePloS one2022
Economic expenditures by recreational anglers in a recovering atlantic bluefin tuna fishery.
Article in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- CapsulatedFrontiers in cellular and infection microbiology · 2026Article
- The genome sequence of Atlantic Bluefin Tuna,Wellcome open research · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The recent return of Atlantic bluefin tuna to northern Europe following the recovery of the east Atlantic stock has sparked substantial public and scientific interest. This is particularly true for recreational anglers in Denmark, who often consider Atlantic bluefin tuna to be the catch of a lifetime. This attitude has previously sustained a substantial recreational fishery for bluefin tuna with annual tournaments in Denmark, which peaked in the 1950s before the subsequent collapse of the stock during the 1960s. Several scientific tagging programs have recruited recreational anglers in recent years to help catch and release tagged bluefin tuna. The anglers' investment of time and money in the scientific tagging projects indicate that the recreational fishery could recover in the future. However, the economic aspects of a potential future recreational bluefin tuna fishery remain unknown. We surveyed anglers participating in a scientific catch and release bluefin tuna fishery in Denmark across three years (2018-2020) and calculated the total annual expenditures associated with the activities. Additionally, we estimated the magnitude of the negative impact (i.e., incidental mortalities) on the bluefin tuna stock. Our results show that total annual expenditures by the recreational anglers approached 1,439,540€, totaling 4,318,620€ between 2018 and 2020. We found that recreational bluefin tuna anglers had mean annual expenditures directly related to the bluefin tuna fishing between 7,047€ and 2,176€ with an associated mortality impact on the stock of less than 1 tonne annually. By comparing the mortality impact to the expenditures, we estimate that each dead Atlantic bluefin tuna during the three study years generated 398,163€ in mean annual expenditures, equivalent to approximately 1636€ kg-1. Our study demonstrates significant economic expenditures among recreational anglers who target Atlantic bluefin tuna. This provides a clear example of how a recovery of marine natural capital and related ecosystem services can support development in the blue economy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.